gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Autologous TILs recognize tumor‑associated peptide–HLA class I complexes via their native TCRs and directly kill target cells through perforin/granzyme-mediated cytolysis (and death receptor pathways).
enzyme_product
Off
epitope
On
variant
Off
isoform
Off
hla_specific
On
gated
Off
other_modifier
Shared TAAs (e.g., cancer-testis antigens) presented on HLA class I
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06190275
disease_id_num_tar_ref
580
drug_id_num_tar_ref
1617